Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy

Simple item page
dc.contributor.authorYe, Hui
dc.contributor.authorWu, Hanghang
dc.contributor.authorMartín Adrados, Beatriz
dc.contributor.authorGómez Del Moral Martín-Consuegra, Manuel María
dc.contributor.authorBañares Cañizares, Rafael
dc.contributor.authorNevzorova, Yulia
dc.contributor.authorMartínez Naves, Eduardo
dc.contributor.authorCubero Palero, Francisco Javier
dc.date.accessioned2024-03-08T10:16:06Z
dc.date.available2024-03-08T10:16:06Z
dc.date.issued2022
dc.description.abstractAcetaminophen (APAP) hepatotoxicity induces endoplasmic reticulum (ER) stress which triggers the unfolded protein response (UPR) in hepatocytes. However, the mechanisms underlying ER stress remain poorly understood, thus reducing the options for exploring new pharmacological therapies for patients with hyperacute liver injury. Eight-to-twelve-week-old C57BL/6J Xbp1-floxed (Xbp1f/f) and hepatocyte-specific knockout Xbp1 mice (Xbp1∆hepa) were challenged with either high dose APAP [500 mg/kg] and sacrificed at early (1-2 h) and late (24 h) stages of hepatotoxicity. Histopathological examination of livers, immunofluorescence and immunohistochemistry, Western blot, real time (RT)-qPCR studies and transmission electron microscopy (TEM) were performed. Pharmacological inhibition of XBP1 using pre-treatment with STF-083010 [STF, 75 mg/kg] and autophagy induction with Rapamycin [RAPA, 8 mg/kg] or blockade with Chloroquine [CQ, 60 mg/kg] was also undertaken in vivo. Cytoplasmic expression of XBP1 coincided with severity of human and murine hyperacute liver injury. Transcriptional and translational activation of the UPR and sustained activation of JNK1/2 were major events in APAP hepatotoxicity, both in a human hepatocytic cell line and in a preclinical model. Xbp1∆hepa livers showed decreased UPR and JNK1/2 activation but enhanced autophagy in response to high dose APAP. Additionally, blockade of XBP1 splicing by STF, mitigated APAP-induced liver injury and without non-specific off-target effects (e.g., CYP2E1 activity). Furthermore, enhanced autophagy might be responsible for modulating CYP2E1 activity in Xbp1∆hepa animals. Genetic and pharmacological inhibition of Xbp1 specifically in hepatocytes ameliorated APAP-induced liver injury by enhancing autophagy and decreasing CYP2E1 expression. These findings provide the basis for the therapeutic restoration of ER stress and/or induction of autophagy in patients with hyperacute liver injury.
dc.description.departmentDepto. de Inmunología, Oftalmología y ORL
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Economía, Comercio y Empresa
dc.description.sponsorshipGerman Research Foundation
dc.description.sponsorshipMinisterio de Ciencia, Innovación y Universidades
dc.description.sponsorshipFundación Científica de la Asociación Española Contra el Cancer
dc.description.statuspub
dc.identifier.citationYe H, Chen C, Wu H, Zheng K, Martín-Adrados B, Caparros E, Francés R, Nelson LJ, Gómez Del Moral M, Asensio I, Vaquero J, Bañares R, Ávila MA, Andrade RJ, Isabel Lucena M, Martínez-Chantar ML, Reeves HL, Masson S, Blumberg RS, Gracia-Sancho J, Nevzorova YA, Martínez-Naves E, Cubero FJ. Genetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy. Cell Death Dis. 2022 Feb 10;13(2):143. doi: 10.1038/s41419-022-04580-8. PMID: 35145060; PMCID: PMC8831621.
dc.identifier.doi10.1038/s41419-022-04580-8
dc.identifier.issn2041-4889
dc.identifier.officialurlhttps://www.nature.com/articles/s41419-022-04580-8
dc.identifier.urihttps://hdl.handle.net/20.500.14352/102059
dc.issue.number2
dc.journal.titleCell death diseases
dc.language.isoeng
dc.page.initial143
dc.publisherElsevier
dc.relation.projectIDSAF2016-78711
dc.relation.projectIDSAF2017-87919-R
dc.relation.projectIDPID2020-11782RB-IOO
dc.relation.projectIDPID2020-117941RB-IOO
dc.relation.projectIDEXOHEP-CM
dc.relation.projectIDS2017/BMD-3727
dc.relation.projectIDY2018/NMT-4949
dc.relation.projectIDUCM-25-2019
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/PID2019-107036RB-I00/ES/FUNCION DE LSECTIN EN LA RESTRICCION DE LA TRANSICION DESDE LA RESPUESTA INNATA A LA RESPUESTA ADAPTATIVA PATOGENICA POR CELULAS T CD4+ EN CIRRHOSIS/
dc.relation.projectIDRTC2019-007125-1
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu611.36
dc.subject.ucmCiencias Biomédicas
dc.subject.ucmGastroenterología y hepatología
dc.subject.ucmInmunología
dc.subject.unesco24 Ciencias de la Vida
dc.subject.unesco2412 Inmunología
dc.titleGenetic and pharmacological inhibition of XBP1 protects against APAP hepatotoxicity through the activation of autophagy
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number13
dspace.entity.typePublication
relation.isAuthorOfPublication00cd7853-9957-498a-953b-f38d6cc185a9
relation.isAuthorOfPublicatione8310664-cd42-4e51-8ad9-86a1cb3766f0
relation.isAuthorOfPublicatione93526bf-b07c-4e2f-a128-2a86044d88e6
relation.isAuthorOfPublication6bae749f-43e7-481d-9c17-3754318969db
relation.isAuthorOfPublication5f15ba54-984a-437d-899a-14563423e77e
relation.isAuthorOfPublication520f2d09-78ca-4d34-b7bc-eb333044ae32
relation.isAuthorOfPublicationb3877679-0fbd-42e6-8541-1efeb2df768a
relation.isAuthorOfPublication.latestForDiscovery00cd7853-9957-498a-953b-f38d6cc185a9
Download
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
41419_2022_Article_4580.pdf
Size:
6.14 MB
Format:
Adobe Portable Document Format
downoload Download
Collections
Artículos